Blue Charm Adherence Secures $4 Million Seed Funding to Advance Innovative Digital Health Platform

Halifax, Nova Scotia — Blue Charm, a leading provider of healthcare technology solutions
empowering patients to access medication and manage their health, is thrilled to announce the successful closing of its $4 million seed investment round.

‍
The financing is led by new co investors Credit Mutuel Equity and Invest Nova Scotia, joined by
follow on participation from original early stage investors. This capital infusion positions Blue
Charm to scale its product offerings, including its patient engagement platform and financial
assistance tools, while deepening its impact across the pharmaceutical and life sciences sectors in its pursuit to transform global healthcare by leveraging real-world data to optimize medication adherence, thereby improving health outcomes.

‍
Investment Highlights:

‍
• New strategic partners: Participation from Credit Mutuel Equity and Invest Nova Scotia
adds financial strength and regional leadership to Blue Charm’s investor base.
• Early-stage supporter reaffirmation: Original early-stage investors have continued their
support with follow-on capital, underlining confidence in the company’s vision and execution.
• Growth acceleration: The raised funds will be deployed toward platform development,
user acquisition, and expansion of solutions for pharmaceutical partners.
“We are energized by the continued support from our founding backers and are delighted to
welcome Credit Mutuel Equity and Invest Nova Scotia aboard,” said Dr. Greg Patey, CEO of Blue Charm. “This seed round enables us to expand our capabilities, working toward the goal of not only making health more accessible, meaningful, and actionable for individuals across Canada and beyond but also to garner a much deeper understanding of the patient journey.”

‍
About Blue Charm

‍
Founded in 2020, Blue Charm Adherence is a Halifax, Nova Scotia based healthcare technology company that provides financial assistance and patient insights programs to patients on behalf of the life sciences industry. In doing so, it collaborates with patient advocacy organizations, disease associations, clinics, and other healthcare technology companies with a focus on improving health outcomes utilizing real world data.

‍
For more information: www.bluecharm.io

‍
About Crédit Mutuel Equity

‍
Crédit Mutuel Equity is the Private Equity arm of Crédit Mutuel Alliance Fédérale and carries out venture capital, growth capital and buyout activities. Crédit Mutuel Equity supports business leaders at all stages of their companies’ development, from seed phase to buyout, by providing them with the means and the time required to implement their transformation plan. Crédit Mutuel Equity brings together a network of over 350 business leaders and entrepreneurs who share similar belief and can benefit from one another’s experience, no matter the nature of their challenges. From its own funds (€5 billion), Crédit Mutuel Equity finances investments tailored to the time horizons and growth strategies of the companies, whether in France, Germany, Switzerland, Belgium or Canada.

‍
For more information: www.creditmutuel-equity.eu

‍
About Invest Nova Scotia

Invest Nova Scotia invests directly in highly innovative early-stage Nova Scotia companies addressing big challenges – alongside institutional, private sector and angel investors from Canada and beyond. In addition to capital, Invest Nova Scotia provides hands-on business guidance, supports good governance, helps open doors to co-investors, and facilitates relationships across the start-up, technology, and venture capital ecosystems.

‍
For more information: www.investnovascotia.ca

‍
Forward-Looking Statements

‍
This release contains forwardlooking statements regarding Blue Charm’s plans and expectations. Actual results may differ due to risks and uncertainties.

‍
Media Contact

‍
Michael Mailman
Blue Charm Adherence Inc.
m.mailman@bluecharm.io
(902) 449-5101

‍